Animal models of adrenocortical tumorigenesis

Molecular and Cellular Endocrinology

Volumn 351, Issue 1, 2012, Pages 78-86

  Beuschlein, Felix ^a   Galac, Sara ^b   Wilson, David B ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Adrenal cortex; Dog; Ferret; Mouse; Oncology

Indexed keywords

MITOTANE; TRILOSTANE;

ADRENAL CORTEX; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX FUNCTION; ADRENALECTOMY; AKR1B7 GENE; AMH GENE; BIOACCUMULATION; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CLINICAL FEATURE; COMPARATIVE ANATOMY; CUSHING SYNDROME; CYCLIN D2 GENE; CYP11A GENE; CYP17 GENE; DISEASE MODEL; DOG; FERRET; GATA4 GENE; GIPR GENE; HISTOPATHOLOGY; INBRED STRAIN; INHIBIN ALPHA GENE; LHR GENE; MARKER GENE; MOUSE STRAIN; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SF1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE; TUMOR XENOGRAFT;

EID: 84857111564     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.09.045     Document Type: Review

References (106)

1. Auchus R.J. Overview of dehydroepiandrosterone biosynthesis. Semin. Reprod. Med. 2004, 22:281-288.
2. Barlaskar F.M., Spalding A.C., Heaton J.H., Kuick R., Kim A.C., Thomas D.G., Giordano T.J., Ben-Josef E., Hammer G.D. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2009, 94:204-212.
3. Benchekroun G., de Fornel-Thibaud P., Lafarge S., Gomez E., Begon D., Delisle F., Moraillon R., Heripret D., Maurey C., Rosenberg D. Trilostane therapy for hyperadrenocorticism in three dogs with adrenocortical metastasis. Vet. Rec. 2008, 163:190-192.
4. Bernichtein S., Alevizaki M., Huhtaniemi I. Is the adrenal cortex a target for gonadotropins?. Trends Endocrinol. Metab. 2008, 19:231-238.
5. Bernichtein S., Petretto E., Jamieson S., Goel A., Aitman T.J., Mangion J.M., Huhtaniemi I.T. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology 2007, 149:651-661.
6. Berthon A., Sahut-Barnola I., Lambert-Langlais S., de Joussineau C., Damon-Soubeyrand C., Louiset E., Taketo M.M., Tissier F., Bertherat J., Lefrancois-Martinez A.M., et al. Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet. 2010, 19:1561-1576.
7. Beuschlein F., Looyenga B.D., Bleasdale S.E., Mutch C., Bavers D.L., Parlow A.F., Nilson J.H., Hammer G.D. Activin induces X-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol. Cell. Biol. 2003, 23:3951-3964.
8. Bielinska M., Genova E., Boime I., Parviainen H., Kiiveri S., Leppaluoto J., Rahman N., Heikinheimo M., Wilson D.B. Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice. Endocrinology 2005, 146:3975-3984.
9. Bielinska M., Kiiveri S., Parviainen H., Mannisto S., Heikinheimo M., Wilson D.B. Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse. Vet. Pathol. 2006, 43:97-117.
10. Bielinska M., Parviainen H., Kiiveri S., Heikinheimo M., Wilson D.B. Origin and molecular pathology of adrenocortical neoplasms. Vet. Pathol. 2009, 46:194-210.
11. Breen M. Update on genomics in veterinary oncology. Top. Companion Anim. Med. 2009, 24:113-121.
12. Burns K.H., Agno J.E., Sicinski P., Matzuk M.M. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin-α knockout mice. Mol. Endocrinol. 2003, 17:2053-2069.
13. Cardoso C.C., Bornstein S.R., Hornsby P.J. Optimizing orthotopic cell transplantation in the mouse adrenal gland. Cell Transplant. 2010, 19:565-572.
14. Compagnone N.A., Bair S.R., Mellon S.H. Characterization of adrenocortical cell lines produced by genetically targeted tumorigenesis in transgenic mice. Steroids 1997, 62:238-243.
15. de Bruin C., Meij B.P., Kooistra H.S., Hanson J.M., Lamberts S.W., Hofland L.J. Cushing's disease in dogs and humans. Horm. Res. 2009, 71(Suppl 1):140-143.
16. Desmarchelier M., Lair S., Dunn M., Langlois I. Primary hyperaldosteronism in a domestic ferret with an adrenocortical adenoma. J. Am. Vet. Med. Assoc. 2008, 233:1297-1301.
17. Doghman M., Cazareth J., Douguet D., Madoux F., Hodder P., Lalli E. Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists. J. Clin. Endocrinol. Metab. 2009, 94:2178-2183.
18. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De M.J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol. 2007, 21:2968-2987.
19. Donovan B.T., Matson C., Kilpatrick M.J. Effect of exposure to long days on the secretion of oestradiol, oestrone, progesterone, testosterone, androstenedione, cortisol and follicle-stimulating hormone in intact and spayed ferrets. J. Endocrinol. 1983, 99:361-368.
20. Eastwood J.M., Elwood C.M., Hurley K.J. Trilostane treatment of a dog with functional adrenocortical neoplasia. J. Small Anim. Pract. 2003, 44:126-131.
21. Else T., Hammer G.D. Genetic analysis of adrenal absence. agenesis and aplasia. Trends Endocrinol. Metab. 2005, 16:458-468.
22. Else T., Trovato A., Kim A.C., Wu Y., Ferguson D.O., Kuick R.D., Lucas P.C., Hammer G.D. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell 2009, 15:465-476.
23. Fidler W.J. Ovarian thecal metaplasia in adrenal glands. Am. J. Clin. Pathol. 1977, 67:318-323.
24. Figueiredo B.C., Cavalli L.R., Pianovski M.A., Lalli E., Sandrini R., Ribeiro R.C., Zambetti G., DeLacerda L., Rodrigues G.A., Haddad B.R. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 2005, 90:615-619.
25. Fox, J.G., Marini, R.P., 1998. Diseases of the endocrine system. In: Biology and Diseases of the Ferret, Lea & Febiger Philadelphia, pp. 291-305.
26. Frank L.A., Rohrbach B.W., Bailey E.M., West J.R., Oliver J.W. Steroid hormone concentration profiles in healthy intact and neutered dogs before and after cosyntropin administration. Domest. Anim. Endocrinol. 2003, 24:43-57.
27. Frigeri C., Tsao J., Cordova M., Schimmer B.P. A polymorphic form of steroidogenic factor-1 is associated with adrenocorticotropin resistance in y1 mouse adrenocortical tumor cell mutants. Endocrinology 2002, 143:4031-4037.
28. Galac S., Buijtels J.J., Mol J.A., Kooistra H.S. Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism. Vet. J. 2010, 183:75-80.
29. Galac S., Kars V.J., Klarenbeek S., Teerds K.J., Mol J.A., Kooistra H.S. Expression of receptors for luteinizing hormone, gastric-inhibitory polypeptide, and vasopressin in normal adrenal glands and cortisol-secreting adrenocortical tumors in dogs. Domest. Anim. Endocrinol. 2010, 39:63-75.
30. Galac S., Kool M.M., Naan E.C., Daminet S., Mol J.A., Kooistra H.S. Expression of the ACTH receptor, steroidogenic acute regulatory protein, and steroidogenic enzymes in canine cortisol-secreting adrenocortical tumors. Domest. Anim. Endocrinol. 2010, 39:259-267.
31. Galac S., Reusch C.E., Kooistra H.S., Rijnberk A. Adrenals. Clinical Endocrinology of Dogs and Cats 2010, 93-154. Schluetersche, Hannover. A. Rijnberk, H.S. Kooistra (Eds.).
32. Gazdar A.F., Oie H.K., Shackleton C.H., Chen T.R., Triche T.J., Myers C.E., Chrousos G.P., Brennan M.F., Stein C.A., La Rocca R.V. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res. 1990, 50:5488-5496.
33. Giordano T.J., Thomas D.G., Kuick R., Lizyness M., Misek D.E., Smith A.L., Sanders D., Aljundi R.T., Gauger P.G., Thompson N.W., et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003, 162:521-531.
34. Gliatto J.M., Alroy J., Schelling S.H., Engler S.J., Dayal Y. A light microscopical, ultrastructural and immunohistochemical study of spindle-cell adrenocortical tumours of ferrets. J. Comp. Pathol. 1995, 113:175-183.
35. Hershkovitz L., Beuschlein F., Klammer S., Krup M., Weinstein Y. Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. Endocrinology 2007, 148:976-988.
36. Jimenez Pelaez M., Bouvy B.M., Dupre G.P. Laparoscopic adrenalectomy for treatment of unilateral adrenocortical carcinomas: technique, complications, and results in seven dogs. Vet. Surg. 2008, 37:444-453.
37. Johnsen I.K., Slawik M., Shapiro I., Hartmann M.F., Wudy S.A., Looyenga B.D., Hammer G.D., Reincke M., Beuschlein F. Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes. J. Endocrinol. 2006, 190:47-57.
38. Kananen K., Markkula M., Mikola M., Rainio E.M., McNeilly A., Huhtaniemi I. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin à-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene. Mol. Endocrinol. 1996, 10:1667-1677.
39. Kananen K., Rilianawati, Paukku T., Markkula M., Rainio E.M., Huhtaniemi I. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Endocrinology 1997, 138:3521-3531.
40. Keegan C.E., Hammer G.D. Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol. Metab. 2002, 13:200-208.
41. Keeney D.S., Jenkins C.M., Waterman M.R. Developmentally regulated expression of adrenal 17a-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 1995, 136:4872-4879.
42. Kim A.C., Reuter A.L., Zubair M., Else T., Serecky K., Bingham N.C., Lavery G.G., Parker K.L., Hammer G.D. Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 2008, 35:2593-2602.
43. Kintzer P.P., Peterson M.E. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms. J. Am. Vet. Med. Assoc. 1994, 205:54-61.
44. Kyles A.E., Feldman E.C., De Cock H.E., Kass P.H., Mathews K.G., Hardie E.M., Nelson R.W., Ilkiw J.E., Gregory C.R. Surgical management of adrenal gland tumors with and without associated tumor thrombi in dogs: 40 cases (1994-2001). J. Am. Vet. Med. Assoc. 2003, 223:654-662.
45. Labelle P., Kyles A.E., Farver T.B., De Cock H.E. Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index. Vet. Pathol. 2004, 41:490-497.
46. Lacroix A., Baldacchino V., Bourdeau I., Hamet P., Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol. Metab. 2004, 15:375-382.
47. Laitinen M.P., Anttonen M., Ketola I., Wilson D.B., Ritvos O., Butzow R., Heikinheimo M. Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors. J. Clin. Endocrinol. Metab. 2000, 85:3476-3483.
48. Li X., Fox J.G., Padrid P.A. Neoplastic diseases in ferrets: 574 cases (1968-1997). J. Am. Vet. Med. Assoc. 1998, 212:1402-1406.
49. Lindblad-Toh K., Wade C.M., Mikkelsen T.S., Karlsson E.K., Jaffe D.B., Kamal M., Clamp M., Chang J.L., Kulbokas E.J., Zody M.C., et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005, 438:803-819.
50. Lindholm J., Juul S., Jorgensen J.O., Astrup J., Bjerre P., Feldt-Rasmussen U., Hagen C., Jorgensen J., Kosteljanetz M., Kristensen L., et al. Incidence and late prognosis of cushing's syndrome: a population-based study. J. Clin. Endocrinol. Metab. 2001, 86:117-123.
51. Logie A., Boudou P., Boccon-Gibod L., Baudin E., Vassal G., Schlumberger M., Le Bouc Y., Gicquel C. Establishment and characterization of a human adrenocortical carcinoma xenograft model. Endocrinology 2000, 141:3165-3171.
52. Looyenga B.D., Hammer G.D. Origin and identity of adrenocortical tumors in inhibin knockout mice. implications for cellular plasticity in the adrenal cortex. Mol. Endocrinol. 2006, 20:2848-2863.
53. Looyenga B.D., Hammer G.D. Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol. Endocrinol. 2007, 21:2440-2457.
54. Luconi M., Mangoni M., Gelmini S., Poli G., Nesi G., Francalanci M., Pratesi N., Cantini G., Lombardi A., Pepi M., et al. Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. Endocrinol. Relat. Cancer 2010, 17:169-177.
55. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
56. Magalhaes M.C. A new crystal-containing cell in human adrenal cortex. J. Cell Biol. 1972, 55:126-133.
57. Matzuk M.M., Finegold M.J., Su J.G., Hsueh A.J., Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992, 360:313-319.
58. Mazzuco T.L., Chabre O., Feige J.J., Thomas M. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. J. Clin. Endocrinol. Metab. 2006, 91:196-203.
59. Mazzuco T.L., Chabre O., Sturm N., Feige J.J., Thomas M. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 2006, 147:782-790.
60. Meij B.P., Mol J.A. Adrenocortical function. Clinical Biochemistry of Domestic Animals 2008, 605-622. Elsevier, Amsterdam. J.J. Kaneko, J.W. Harvey, M.L. Bruss (Eds.).
61. Meler E.N., Scott-Moncrieff J.C., Peter A.T., Bennett S., Ramos-Vara J., Salisbury S.K., Naughton J.F. Cyclic estrous-like behavior in a spayed cat associated with excessive sex-hormone production by an adrenocortical carcinoma. J. Feline Med. Surg. 2011, 13:473-478.
62. Miwa Y., Kurosawa A., Ogawa H., Nakayama H., Sasai H., Sasaki N. Neoplasitic diseases in ferrets in Japan: a questionnaire study for 2000 to 2005. J. Vet. Med. Sci. 2009, 71:397-402.
63. Nakamura Y., Gang H.X., Suzuki T., Sasano H., Rainey W.E. Adrenal changes associated with adrenarche. Rev. Endocrinol. Metab. Disord. 2009, 10:19-26.
64. Newman S.J., Bergman P.J., Williams B., Scase T., Craft D. Characterization of spindle cell compenent of ferret (Mustela putorius furo) adrenal cortical neoplasms - correlation to clinical parameters and prognosis. Vet. Comp. Oncol. 2004, 2:113-124.
65. Patterson M.M., Rogers A.B., Schrenzel M.D., Marini R.P., Fox J.G. Alopecia attributed to neoplastic ovarian tissue in two ferrets. Comp. Med. 2003, 53:213-217.
66. Peterson R.A., Kiupel M., Bielinska M., Kiiveri S., Heikinheimo M., Capen C.C., Wilson D.B. Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Vet. Pathol. 2004, 41:446-449.
67. Peterson R.A., Kiupel M., Capen C.C. Adrenal cortical carcinomas with myxoid differentiation in the domestic ferret (Mustela putorius furo). Vet. Pathol. 2003, 40:136-142.
68. Potts G.O., Creange J.E., Hardomg H.R., Schane H.P. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 1978, 32:257-267.
69. Rilianawati, Kero J., Paukku T., Huhtaniemi I. Long-term testosterone treatment prevents gonadal and adrenal tumorigenesis of mice transgenic for the mouse inhibin-à subunit promoter/simian virus 40 T-antigen fusion gene. J. Endocrinol. 2000, 166:77-85.
70. Rilianawati, Paukku T., Kero J., Zhang F.P., Rahman N., Kananen K., Huhtaniemi I. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin à-subunit promoter/simian virus 40 T-antigen fusion gene. Mol. Endocrinol. 1998, 12:801-809.
71. Rivera P., von Euler H. Molecular biological aspects on canine and human mammary tumors. Vet. Pathol. 2011, 48:132-146.
72. Romberger C.F., Wong T.W. Thecal metaplasia in the adrenal gland of a man with acquired bilateral testicular atrophy. Arch. Pathol. Lab. Med. 1989, 113:1071-1075.
73. Rosenthal K.L. Adrenal gland disease in ferrets. Vet. Clin. North Am. Small Anim. Pract. 1997, 27:401-418.
74. Rosenthal K.L., Peterson M.E. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism. J. Am. Vet. Med. Assoc. 1996, 209:1097-1102.
75. Rosenthal K.L., Peterson M.E., Quesenberry K.E., Hillyer E.V., Beeber N.L., Moroff S.D., Lothrop C.D. Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991). J. Am. Vet. Med. Assoc. 1993, 203:271-275.
76. Rosol T.J., Yarrington J.T., Latendresse J., Capen C.C. Adrenal gland: structure, function, and mechanisms of toxicity. Toxicol. Pathol. 2001, 29:41-48.
77. Ryan K.D. Hormonal correlates of photoperiod-induced puberty in a reflex ovulator, the female ferret (Mustela furo). Biol. Reprod. 1984, 31:925-935.
78. Sahut-Barnola I., Lefrancois-Martinez A.M., Jean C., Veyssiere G., Martinez A. Adrenal tumorigenesis targeted by the corticotropin-regulated promoter of the aldo-keto reductase AKR1B7 gene in transgenic mice. Endocr. Res. 2000, 26:885-898.
79. Sbiera S., Schmull S., Assie G., Voelker H.U., Kraus L., Beyer M., Ragazzon B., Beuschlein F., Willenberg H.S., Hahner S., et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J. Clin. Endocrinol. Metab. 2010, 95:E161-171.
80. Schoemaker N.J., Kuijten A.M., Galac S. Luteinizing hormone-dependent Cushing's syndrome in a pet ferret (Mustela putorius furo). Domest. Anim. Endocrinol. 2008, 34:278-283.
81. Schoemaker N.J., Schuurmans M., Moorman H., Lumeij J.T. Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets. J. Am. Vet. Med. Assoc. 2000, 216:195-197.
82. Schoemaker N.J., Teerds K.J., Mol J.A., Lumeij J.T., Thijssen J.H., Rijnberk A. The role of luteinizing hormone in the pathogenesis of hyperadrenocorticism in neutered ferrets. Mol. Cell. Endocrinol. 2002, 197:117-125.
83. Schoemaker N.J., van D.R., Muijlaert B., Kik M.J., Kuijten A.M., de Jong F.H., Trigg T.E., Kruitwagen C.L., Mol J.A. Use of a gonadotropin releasing hormone agonist implant as an alternative for surgical castration in male ferrets (Mustela putorius furo). Theriogenology 2008, 70:161-167.
84. Smith M., Schulman F.Y. Subcutaneous neoplasms of the ventral abdomen with features of adrenocortical tumors in two ferrets. Vet. Pathol. 2007, 44:951-955.
85. Sun X., Sui H., Fisher J.T., Yan Z., Liu X., Cho H.J., Joo N.S., Zhang Y., Zhou W., Yi Y., et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 2010, 120:3149-3160.
86. Thompson G.B., Young W.F. Adrenal incidentaloma. Curr. Opin. Oncol. 2003, 15:84-90.
87. Tissier F., Cavard C., Groussin L., Perlemoine K., Fumey G., Hagnere A.M., Rene-Corail F., Jullian E., Gicquel C., Bertagna X., et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005, 65:7622-7627.
88. Tremblay J.J., Viger R.S. GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 2001, 142:977-986.
89. van der Vlugt-Meijer R.H., Meij B.P., van den Ingh T.S., Rijnberk A., Voorhout G. Dynamic computed tomography of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J. Vet. Intern. Med. 2003, 17:773-780.
90. van der Vlugt-Meijer R.H., Voorhout G., Meij B.P. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Mol. Cell. Endocrinol. 2002, 197:81-87.
91. van Sluijs F.J., Sjollema B.E., Voorhout G., van den Ingh T.S., Rijnberk A. Results of adrenalectomy in 36 dogs with hyperadrenocorticism caused by adreno-cortical tumour. Vet. Q. 1995, 17:113-116.
92. Voorhout G., Rijnberk A., Sjollema B.E., van den Ingh T.S. Nephrotomography and ultrasonography for the localization of hyperfunctioning adrenocortical tumors in dogs. Am. J. Vet. Res. 1990, 51:1280-1285.
93. Vuorenoja S., Rivero-Muller A., Kiiveri S., Bielinska M., Heikinheimo M., Wilson D.B., Huhtaniemi I.T., Rahman N.A. Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6. Mol. Cell. Endocrinol. 2007, 269:38-45.
94. Vuorenoja S., Rivero-Muller A., Ziecik A.J., Huhtaniemi I., Toppari J., Rahman N.A. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate. Endocrinol. Relat. Cancer 2008, 15:635-648.
95. Wagner R.A., Bailey E.M., Schneider J.F., Oliver J.W. Leuprolide acetate treatment of adrenocortical disease in ferrets. J. Am. Vet. Med. Assoc. 2001, 218:1272-1274.
96. Wagner R.A., Piche C.A., Jochle W., Oliver J.W. Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease. Am. J. Vet. Res. 2005, 66:910-914.
97. Wagner S., Kiupel M., Peterson R.A., Heikinheimo M., Wilson D.B. Cytochrome b5 expression in gonadectomy-induced adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Vet. Pathol. 2008, 45:439-442.
98. Weber M.M., Auernhammer C.J., Kiess W., Engelhardt D. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. Eur. J. Endocrinol. 1997, 136:296-303.
99. Weiss C.A., Scott M.V. Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996). J. Am. Anim. Hosp. Assoc. 1997, 33:487-493.
100. Weiss C.A., Williams B.H., Scott J.B., Scott M.V. Surgical treatment and long-term outcome of ferrets with bilateral adrenal tumors or adrenal hyperplasia: 56 cases (1994-1997). J. Am. Vet. Med. Assoc. 1999, 215:820-823.
101. Wenger M., Sieber-Ruckstuhl N.S., Muller C., Reusch C.E. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Am. J. Vet. Res. 2004, 65:1245-1250.
102. West A.N., Ribeiro R.C., Jenkins J., Rodriguez-Galindo C., Figueiredo B.C., Kriwacki R., Zambetti G.P. Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma. Cancer Res. 2006, 66:5056-5062.
103. Willeberg P., Priester W.A. Epidemiological aspects of clinical hyperadrenocorticims in dogs (canine Cushing's syndrome). J. Am. Anim. Hosp. Assoc. 1982, 18:717-724.
104. Wong T.W., Warner N.E. Ovarian thecal metaplasia in the adrenal gland. Arch. Pathol. 1971, 92:319-328.
105. Woolley G.W., Little C.C. The incidence of adrenal cortical carcinoma in gonadectomized female mice of the extreme dilution strain. I. Observations on the adrenal cortex. Cancer Res. 1945, 5:193-202.
106. Zubair M., Parker K.L., Morohashi K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol. Cell. Biol. 2008, 28:7030-7040.